These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23721076)

  • 21. Insights into mechanisms behind arteriogenesis: what does the future hold?
    van Oostrom MC; van Oostrom O; Quax PH; Verhaar MC; Hoefer IE
    J Leukoc Biol; 2008 Dec; 84(6):1379-91. PubMed ID: 18678607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of collateral artery growth: travelling further down the road to clinical application.
    Schirmer SH; van Nooijen FC; Piek JJ; van Royen N
    Heart; 2009 Mar; 95(3):191-7. PubMed ID: 19144878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art.Net.-2 Trial).
    Buschmann EE; Utz W; Pagonas N; Schulz-Menger J; Busjahn A; Monti J; Maerz W; le Noble F; Thierfelder L; Dietz R; Klauss V; Gross M; Buschmann IR;
    Eur J Clin Invest; 2009 Oct; 39(10):866-75. PubMed ID: 19572918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary collaterals--insights in molecular determinants and prognostic relevance.
    Regieli JJ; Nathoe HM; Koerselman J; van der Graaf Y; Grobbee DE; Doevendans PA
    Int J Cardiol; 2007 Mar; 116(2):139-43. PubMed ID: 16828902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic angiogenesis: review of current concepts and future directions.
    Abo-Auda W; Benza RL
    J Heart Lung Transplant; 2003 Apr; 22(4):370-82. PubMed ID: 12681415
    [No Abstract]   [Full Text] [Related]  

  • 26. Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice.
    Schirmer SH; Fledderus JO; Bot PT; Moerland PD; Hoefer IE; Baan J; Henriques JP; van der Schaaf RJ; Vis MM; Horrevoets AJ; Piek JJ; van Royen N
    Circ Res; 2008 May; 102(10):1286-94. PubMed ID: 18420941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of inflammatory cytokines on arteriogenesis.
    Buschmann I; Heil M; Jost M; Schaper W
    Microcirculation; 2003 Jun; 10(3-4):371-9. PubMed ID: 12851653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The collateral circulation of the heart.
    Meier P; Schirmer SH; Lansky AJ; Timmis A; Pitt B; Seiler C
    BMC Med; 2013 Jun; 11():143. PubMed ID: 23735225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors causing variability in formation of coronary collaterals during coronary artery disease.
    Balakrishnan S; Senthil Kumar B
    Folia Morphol (Warsz); 2022; 81(4):815-824. PubMed ID: 34699051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of collateral circulation in coronary heart disease.
    Berry C; Balachandran KP; L'Allier PL; Lespérance J; Bonan R; Oldroyd KG
    Eur Heart J; 2007 Feb; 28(3):278-91. PubMed ID: 17218452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects.
    Guo M; Shi JH; Wang PL; Shi DZ
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):130-141. PubMed ID: 29025278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-15b-5p Regulates Collateral Artery Formation by Targeting AKT3 (Protein Kinase B-3).
    Zhu LP; Zhou JP; Zhang JX; Wang JY; Wang ZY; Pan M; Li LF; Li CC; Wang KK; Bai YP; Zhang GG
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):957-968. PubMed ID: 28254819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Human Coronary Collateral Circulation, Its Extracardiac Anastomoses and Their Therapeutic Promotion.
    Bigler MR; Seiler C
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of diabetes mellitus on coronary collateral flow: an answer to an old controversy.
    Zbinden R; Zbinden S; Billinger M; Windecker S; Meier B; Seiler C
    Heart; 2005 Oct; 91(10):1289-93. PubMed ID: 16162618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arteriogenesis: basic mechanisms and therapeutic stimulation.
    Grundmann S; Piek JJ; Pasterkamp G; Hoefer IE
    Eur J Clin Invest; 2007 Oct; 37(10):755-66. PubMed ID: 17764463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The molecular bypass: an established method for revascularisation of non-operable PAD patients or merely a future vision].
    Herold J; Said S; Braun-Dullaeus R
    Zentralbl Chir; 2014 Oct; 139(5):508-17. PubMed ID: 24089345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical interventions to influence arteriogenesis: new concepts to treat ischemic heart disease.
    Hoefer IE; Piek JJ; Pasterkamp G
    Curr Med Chem; 2006; 13(9):979-87. PubMed ID: 16611079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy.
    Al Kaabi A; Traupe T; Stutz M; Buchs N; Heller M
    PLoS One; 2012; 7(10):e46822. PubMed ID: 23056467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiologic assessment of the coronary collateral circulation in transplanted human hearts.
    Johnson TH; Das GS; McGinn AL; Christensen BV; Meyer SM; Wilson RF
    J Heart Lung Transplant; 1994; 13(5):840-6. PubMed ID: 7803425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A potential evidence to explain the reason behind the devastating prognosis of coronary artery disease in uraemic patients: renal insufficiency is associated with poor coronary collateral vessel development.
    Sezer M; Ozcan M; Okcular I; Elitok A; Umman S; Umman B; Tayyareci Y; Olcay A; Nisanci Y; Bilge AK; Meric M
    Int J Cardiol; 2007 Feb; 115(3):366-72. PubMed ID: 16793151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.